Toll-like receptor modulation in cardiovascular disease: A target for intervention?

Gábor Földes, Stephan von Haehling, Stefan D. Anker

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Toll-like receptors (TLRs) form a family of pattern recognition receptors that have emerged as key mediators of innate immunity. These receptors sense invading microbes and initiate the immune response. TLR-mediated inflammation is an important pathogenic link between innate immunity and a diverse panel of clinical disorders. Among the processes in which TLRs play a role are cardiovascular disorders such as cardiac ischaemia, coronary artery disease, ventricular remodelling, cancer angiogenesis or transplant rejection. From these, many important opportunities for disease modification through TLR signalling manipulation can be imagined. Their role as potential targets for therapeutic intervention is just beginning to be appreciated and this article reviews the current status of these treatment strategies for cardiovascular disease.

Original languageEnglish
Pages (from-to)857-871
Number of pages15
JournalExpert Opinion on Investigational Drugs
Volume15
Issue number8
DOIs
Publication statusPublished - Aug 2006

Fingerprint

Toll-Like Receptors
Cardiovascular Diseases
Innate Immunity
Pattern Recognition Receptors
Ventricular Remodeling
Graft Rejection
Coronary Artery Disease
Ischemia
Inflammation
Neoplasms
Therapeutics

Keywords

  • Cardiovascular disease
  • Drug development
  • Innate immune system
  • Toll-like receptors

ASJC Scopus subject areas

  • Pharmacology

Cite this

Toll-like receptor modulation in cardiovascular disease : A target for intervention? / Földes, Gábor; von Haehling, Stephan; Anker, Stefan D.

In: Expert Opinion on Investigational Drugs, Vol. 15, No. 8, 08.2006, p. 857-871.

Research output: Contribution to journalArticle

Földes, Gábor ; von Haehling, Stephan ; Anker, Stefan D. / Toll-like receptor modulation in cardiovascular disease : A target for intervention?. In: Expert Opinion on Investigational Drugs. 2006 ; Vol. 15, No. 8. pp. 857-871.
@article{06f0708000034eae8200e5778944399c,
title = "Toll-like receptor modulation in cardiovascular disease: A target for intervention?",
abstract = "Toll-like receptors (TLRs) form a family of pattern recognition receptors that have emerged as key mediators of innate immunity. These receptors sense invading microbes and initiate the immune response. TLR-mediated inflammation is an important pathogenic link between innate immunity and a diverse panel of clinical disorders. Among the processes in which TLRs play a role are cardiovascular disorders such as cardiac ischaemia, coronary artery disease, ventricular remodelling, cancer angiogenesis or transplant rejection. From these, many important opportunities for disease modification through TLR signalling manipulation can be imagined. Their role as potential targets for therapeutic intervention is just beginning to be appreciated and this article reviews the current status of these treatment strategies for cardiovascular disease.",
keywords = "Cardiovascular disease, Drug development, Innate immune system, Toll-like receptors",
author = "G{\'a}bor F{\"o}ldes and {von Haehling}, Stephan and Anker, {Stefan D.}",
year = "2006",
month = "8",
doi = "10.1517/13543784.15.8.857",
language = "English",
volume = "15",
pages = "857--871",
journal = "Expert Opinion on Investigational Drugs",
issn = "1354-3784",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Toll-like receptor modulation in cardiovascular disease

T2 - A target for intervention?

AU - Földes, Gábor

AU - von Haehling, Stephan

AU - Anker, Stefan D.

PY - 2006/8

Y1 - 2006/8

N2 - Toll-like receptors (TLRs) form a family of pattern recognition receptors that have emerged as key mediators of innate immunity. These receptors sense invading microbes and initiate the immune response. TLR-mediated inflammation is an important pathogenic link between innate immunity and a diverse panel of clinical disorders. Among the processes in which TLRs play a role are cardiovascular disorders such as cardiac ischaemia, coronary artery disease, ventricular remodelling, cancer angiogenesis or transplant rejection. From these, many important opportunities for disease modification through TLR signalling manipulation can be imagined. Their role as potential targets for therapeutic intervention is just beginning to be appreciated and this article reviews the current status of these treatment strategies for cardiovascular disease.

AB - Toll-like receptors (TLRs) form a family of pattern recognition receptors that have emerged as key mediators of innate immunity. These receptors sense invading microbes and initiate the immune response. TLR-mediated inflammation is an important pathogenic link between innate immunity and a diverse panel of clinical disorders. Among the processes in which TLRs play a role are cardiovascular disorders such as cardiac ischaemia, coronary artery disease, ventricular remodelling, cancer angiogenesis or transplant rejection. From these, many important opportunities for disease modification through TLR signalling manipulation can be imagined. Their role as potential targets for therapeutic intervention is just beginning to be appreciated and this article reviews the current status of these treatment strategies for cardiovascular disease.

KW - Cardiovascular disease

KW - Drug development

KW - Innate immune system

KW - Toll-like receptors

UR - http://www.scopus.com/inward/record.url?scp=33746839212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746839212&partnerID=8YFLogxK

U2 - 10.1517/13543784.15.8.857

DO - 10.1517/13543784.15.8.857

M3 - Article

C2 - 16859390

AN - SCOPUS:33746839212

VL - 15

SP - 857

EP - 871

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

SN - 1354-3784

IS - 8

ER -